The risks of using non-specific outcome measures to capture activities of daily living in myotonic dystrophy type 2

Affiliations

¹ Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands. Electronic address: t.hamadeh@maastrichtuniversity.nl.
² Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands.
³ Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands; Department of Neurology, Curacao Medical Center, J.H.J. Hamelbergweg z/n, Willemstad, Curaçao.

Comment

Tatiana Hamadeh et al. Neuromuscul Disord. 2021 Apr.

. 2021 Apr;31(4):367-368.

doi: 10.1016/j.nmd.2021.02.008. Epub 2021 Feb 13.

¹ Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands. Electronic address: t.hamadeh@maastrichtuniversity.nl.
² Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands.
³ Department of Neurology, Maastricht University Medical Center, P.O. Box 5800, Maastricht, the Netherlands; Department of Neurology, Curacao Medical Center, J.H.J. Hamelbergweg z/n, Willemstad, Curaçao.

No abstract available

Comment in

The risks of using non-specific outcome measures to capture activities of daily living in myotonic dystrophy type 2 - Response.
On Behalf Of All Authors, Montagnese F, Schoser B. On Behalf Of All Authors, et al. Neuromuscul Disord. 2021 Apr;31(4):369. doi: 10.1016/j.nmd.2021.02.016. Epub 2021 Feb 20. Neuromuscul Disord. 2021. PMID: 33741229 No abstract available.

How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F, Rastelli E, Stahl K, Massa R, Schoser B. Montagnese F, et al. Neuromuscul Disord. 2020 Oct;30(10):796-806. doi: 10.1016/j.nmd.2020.07.011. Epub 2020 Aug 1. Neuromuscul Disord. 2020. PMID: 32888768